[1] Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J]. Cell, 1993, 75(5):843-854.
[2] Lee Y, Ahn C, Han J, et al. The nuclear RNase Ⅲ Drosha initiates microRNA processing[J]. Nature, 2003, 425(6956):415-419.
[3] Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact[J]. J Clin Oncol, 2009, 27(34):5848-5856.
[4] Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2):281-297.
[5] Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers[J]. Proc Natl Acad Sci USA, 2004, 101(9):2999-3004.
[6] Salzman DW, Weidhaas JB. SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer[J]. Pharmacol Ther, 2013, 137(1):55-63.
[7] Duan S, Mi S, Zhang W, et al. Comprehensive analysis of the impact of SNPs and CNVs on human microRNAs and their regulatory genes[J]. RNA Biol, 2009, 6(4):412-425.
[8] Mishra PJ, Bertino JR. MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine[J]. Pharmacogenomics, 2009, 10(3):399-416.
[9] Duan R, Pak C, Jin P. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA[J]. Hum Mol Genet, 2007, 16(9):1124-1131.
[10] Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research[J]. Nat Rev Cancer, 2010, 10(6):389-402.
[11] Georges M, Clop A, Marcq F, et al. Polymorphic microRNA-target interactions: a novel source of phenotypic variation[J]. Cold Spring Harb Symp Quant Biol, 2006, 71:343-350.
[12] Yu Z, Li Z, Jolicoeur N, et al. Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers[J]. Nucleic Acids Res, 2007, 35(13):4535-4341.
[13] Gong J, Tong Y, Zhang HM, et al. Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis[J]. Hum Mutat, 2012, 33(1):254-263.
[14] Taganov KD, Boldin MP, Chang KJ, et al. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses[J]. Proc Natl Acad Sci USA, 2006, 103(33):12481-12486.
[15] Xu T, Zhu Y, Wei QK, et al. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma[J]. Carcinogenesis, 2008, 29(11):2126-2131.
[16] Jazdzewski K, Murray EL, Franssila K, et al. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma[J]. Proc Natl Acad Sci USA, 2008, 105(20):7269-7274.
[17] Zeng Y, Sun QM, Liu NN, et al. Correlation between pre-miR-146a C/G polymorphism and gastric cancer risk in Chinese population[J]. World J Gastroenterol, 2010, 16(28):3578-3583.
[18] Okubo M, Tahara T, Shibata T, et al. Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population[J]. Helicobacter, 2010, 15(6):524-531.
[19] Shen J, Ambrosone CB, DiCioccio RA, et al. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis[J]. Carcinogenesis, 2008, 29(10):1963-1966.
[20] Lian H, Wang L, Zhang J. Increased risk of breast cancer associated with CC genotype of Has-miR-146a Rs2910164 polymorphism in Europeans[J]. PLoS One, 2012, 7(2):e31615.
[21] Zhou J, Lv R, Song X, et al. Association between two genetic variants in miRNA and primary liver cancer risk in the Chinese population[J]. DNA Cell Biol, 2012, 31(4):524-530.
[22] Linhares JJ, Azevedo M Jr, Siufi AA, et al. Evaluation of single nucleotide polymorphisms in microRNAs (hsa-miR-196a2 rs11614913 C/T) from Brazilian women with breast cancer[J]. BMC Med Genet, 2012, 13:119.
[23] Hu Z, Chen J, Tian T, et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival[J]. J Clin Invest, 2008, 118(7):2600-2608.
[24] Peng S, Kuang Z, Sheng C, et al. Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population[J]. Dig Dis Sci, 2010, 55(8):2288-2293.
[25] Alshatwi AA, Shafi G, Hasan TN, et al. Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients[J]. PLoS One, 2012, 7(2):e30049.
[26] Arisawa T, Tahara T, Shibata T, et al. A polymorphism of microRNA 27a genome region is associated with the development of gastric mucosal atrophy in Japanese male subjects[J]. Dig Dis Sci, 2007, 52(7):1691-1697.
[27] Sun Q, Gu H, Zeng Y, et al. Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression[J]. Cancer Sci, 2010, 101(10):2241-2247.
[28] Shi D, Li P, Ma L, et al. A genetic variant in pre-miR-27a is associated with a reduced renal cell cancer risk in a Chinese population[J]. PLoS One, 2012, 7(10):e46566.
[29] Yang R, Schlehe B, Hemminki K, et al. A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk[J]. Breast Cancer Res Treat, 2010, 121(3):693-702.
[30] Liu Z, Li G, Wei S, et al. Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck[J]. Cancer, 2010, 116(20):4753-4760.
[31] Hu Z, Chen X, Zhao Y, et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer[J]. J Clin Oncol, 2010, 28(10):1721-1726.
[32] Liu X, Zhang Z, Sun L, et al. MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4[J]. Carcinogenesis, 2011, 32(12):1798-1805.
[33] Huang AJ, Yu KD, Li J, et al. Polymorphism rs4919510:C> G in mature sequence of human microRNA-608 contributes to the risk of HER2-positive breast cancer but not other subtypes[J]. PLoS One, 2012, 7(5):e35252.
[34] Mu YP, Su XL. Polymorphism in pre-miR-30c contributes to gastric cancer risk in a Chinese population[J]. Med Oncol, 2012, 29(3):1723-1732.
[35] Smith RA, Jedlinski DJ, Gabrovska PN, et al. A genetic variant located in miR-423 is associated with reduced breast cancer risk[J]. Cancer Genomics Proteomics, 2012, 9(3):115-118.
[36] Ma H, Yuan H, Yuan Z, et al. Genetic variations in key microRNA processing genes and risk of head and neck cancer: a case-control study in Chinese population[J]. PLoS One, 2012, 7(10):e47544.
[37] Wang K, Li J, Guo H, et al. MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis[J]. Carcinogenesis, 2012, 33(11):2147-2154.
[38] Lin Y, Nie Y, Zhao J, et al. Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility[J]. Carcinogenesis, 2012, 33(12):2377-2383.
[39] Ryan BM, McClary AC, Valeri N, et al. rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer[J]. PLoS One, 2012, 7(5):e36306.
[40] Smits KM, Paranjape T, Nallur S, et al. A let-7 microRNA SNP in the KRAS 3′UTR is prognostic in early-stage colorectal cancer[J]. Clin Cancer Res, 2011, 17(24):7723-7731.
[41] Naccarati A, Pardini B, Stefano L, et al. Polymorphisms in miRNA-binding sites of nucleotide excision repair genes and colorectal cancer risk[J]. Carcinogenesis, 2012, 33(7):1346-1351.
[42] Guo Z, Wu C, Wang X, et al. A polymorphism at the miR-502 binding site in the 3′- untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome[J]. Int J Cancer, 2012, 131(6):1318-1322.
[43] Liu Y, Zhang Y, Wen J, et al. A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma[J]. PLoS One, 2012, 7(2):e32230.
[44] Ma H, Yuan H, Yuan Z, et al. Genetic variations in key microRNA processing genes and risk of head and neck cancer: a case-control study in Chinese population[J]. PLoS One, 2012, 7(10):e47544.
[45] Zhang X, Yang H, Lee JJ, et al. MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer[J]. Carcinogenesis, 2010, 31(12):2118-2123.
[46] Luo J, Cai Q, Wang W, et al. A microRNA-7 binding site polymorphism in HOXB5 leads to differential gene expression in bladder cancer[J]. PLoS One, 2012, 7(6):e40127.
[47] Feng N, Xu B, Tao J, et al. A miR-125b binding site polymorphism in bone morphogenetic protein membrane receptor type IB gene and prostate cancer risk in China[J]. Mol Biol Rep, 2012, 39(1):369-373.
[48] Wang C, Guo Z, Wu C, et al. A polymorphism at the miR-502 binding site in the 3′ untranslated region of the SET8 gene is associated with the risk of epithelial ovarian cancer[J]. Cancer Genet, 2012, 205(7-8):373-376.
[49] Liang D, Meyer L, Chang DW, et al. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response[J]. Cancer Res, 2010, 70(23):9765-9776.
[50] Wynendaele J, Bhnke A, Leucci E, et al. An illegitimate microRNA target site within the 3′UTR of MDM4 affects ovarian cancer progression and chemosensitivity[J]. Cancer Res, 2010, 70(23):9641-9649. |